Efficacy and Safety of a Citrate-based Anticoagulation With Calcium-free Phosphate-containing Fluid in Renal Replacement Therapy

NCT04215965 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Critical Care

Interventions

DRUG: Biphozyl (dialysate and replacement)
DRUG: Prismocal B22 (dialysate) + phoxilium (replacement)

Sponsor

Assistance Publique Hopitaux De Marseille